Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Laptop heat exposure causes rare skin rash and discoloration

8

Sep 2026

Laptop heat exposure causes rare skin rash and discoloration

Balancing an electronic device on bare skin risks disfiguration, doctors warn in the online journal BMJ Case Reports, after treating a child with skin discoloration and a 'fishnet' rash -hallmarks of erythema ab igne-caused by repeated exposure to the low grade heat from a laptop.

COVID-19 linked to lower subsequent risk of type 1 diabetes

8

Sep 2026

COVID-19 linked to lower subsequent risk of type 1 diabetes

New research to be presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2) shows that people who have had COVID-19 have a lower, rather than higher, risk of subsequent development of type 1 diabetes (T1D).

Integrated mental health care could transform Canada's primary care

8

Sep 2026

Integrated mental health care could transform Canada's primary care

As Prime Minister Mark Carney prepares to host the inaugural Canada Investment Summit in Toronto this September, a new review co-led by researchers at UBC argues that the country is leaving one of its largest economic and health-care system opportunities untouched: the integration of psychological care into primary care.

Rice, seafood and water may help explain striking differences in metal exposure across US communities

8

Sep 2026

Rice, seafood and water may help explain striking differences in metal exposure across US communities

Researchers compared urinary trace-metal profiles across 666 adults from six ethnic groups in three US cohorts, with up to 19 elements measured and paired serum measurements available for the Asian Indian MASALA cohort. Distinct metal patterns emerged across populations, with the findings suggesting that diet, drinking-water sources, regional hydrogeology, urban-rural conditions, smoking, and physiological handling may all contribute to differences in exposure profiles.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.